NCT03510637View on ClinicalTrials.gov

"Real Life Evaluation of Efficacy and Safety of Direct Antiviral Agents (DAAs) for the Treatment of Hepatitis C Virus in Egypt"

UnknownOBSERVATIONAL

Enrollment

7,500

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions

Chronic Hepatitis C

Trial Locations (3)

Unknown

RECRUITING

El Fatemia El Kahera Centre, Cairo

RECRUITING

National Hepatology and Tropical Medicine Institute, Cairo

RECRUITING

New Cairo Hospital, Cairo

Sponsors

Collaborators (1)

Institut Pasteur

All Listed Sponsors

collaborator

Institut Pasteur

INDUSTRY

lead

ANRS, Emerging Infectious Diseases

OTHER_GOV